Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Alemtuzumab × Clear all

Sponsor

Conditions

Leukemia 27 Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma 16 Myelodysplastic Syndromes 11 Hodgkin Disease 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Leukemia, Myeloid, Acute 7 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Recurrence 5 Myeloproliferative Disorders 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myeloid, Chronic-Phase 5 Hematologic Neoplasms 5 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, B-Cell, Marginal Zone 4 Anemia, Aplastic 4 Waldenstrom Macroglobulinemia 3 Sezary Syndrome 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Large Granular Lymphocytic 3 Immunoblastic Lymphadenopathy 3 Hematologic Diseases 3

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡